Avinger Cash Flow from Investing Activities 2013-2024 | AVGR
Avinger cash flow from investing activities from 2013 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
| Avinger Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $-1 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.002B | $0.008B |
| Avinger, Inc. is engaged in designing, manufacturing and selling image-guided, catheter-based systems to treat peripheral arterial disease. The company's product consists of Lightbox imaging console, Wildcat, Kittycat, Ocelot, Ocelot PIXL, Ocelot MVRX and Juicebox. Avinger, Inc. is based in Redwood City, California. | |||